LCMS webinars focusing on Dissolution

Biorelevant Dissolution media has long been a topic of drug release testing and has become a stronger focus in the pharmaceutical industry.

The discussion will highlight some advantages and disadvantages of PQ and MQ approaches and give you some insights on which approach could work best for your lab.

How does the Dissolution workflow and equipment fit into the move to a connected lab environment and where do we see challenges but also opportunities?

Does Amino Acid analysis impact different stages of drug discovery or the manufacturing process? Is it important for protein and peptide identification and quantitation?​

We will explore tools and techniques that address the challenges of these types of analysis by examining several examples and case studies.

Join us to get an update on the latest changes and additions to USP chapter <1724>.

Let’s take a trip to the vet and explore our options.

Join us for a discussions on challenges and how they can be overcome.

Let’s take a closer look at all these questions and try to answer them with our group of experts from the DDG panel and industry experts.

Join the DDG expert panel for an update on the Key Regulatory and Compendial Dissolution Updates from 2021.